| Literature DB >> 23115426 |
Abdolreza Najafi Anaraki1, Mohamadzaki Abbasi, Abdolrasoul Anvarypour, Niloofar Motamed.
Abstract
BACKGROUND: Clinical investigations have reported several anesthetic properties of intrathecal injections of meperidine. The purpose of this study was to investigate the effect of adding meperidine to intrathecal heavy lidocaine on hemodynamic changes and blood loss in patients undergoing elective suprapubic open prostatectomy.Entities:
Keywords: Blood loss; intrathecal; lidocaine; meperidine
Year: 2012 PMID: 23115426 PMCID: PMC3470293
Source DB: PubMed Journal: Iran J Med Sci ISSN: 0253-0716
The demographic and baseline hemodynamic data (mean±SD) of patients in the control and experiemntal groups
|
|
|
| |
|---|---|---|---|
| Age (year) | 68.11±8.11 | 67.23± 8.36 | 0.64 |
| Weight (Kg) | 73.68±9.58 | 70.97±12.32 | 0.28 |
| Preop-hemoglobin (g/dl) | 13.5±1.96 | 13.43±2.07 | 0.88 |
| Duration of operation (min) | 74.24±11.6 | 72.42±11.68 | 0.49 |
| Heart rate (beats/min) | 79.08±13.11 | 80.10± 10.88 | 0.71 |
| SBP (mmHg) | 139.74±31.70 | 141.59±28.72 | 0.78 |
| DBP (mmHg) | 77.92±14.81 | 78.26±12.40 | 0.91 |
Preop: preoperative; SBP: systolic blood pressure; DAP: diastolic blood pressure
Heart rate (beats/min) of the experimental and control groups during the operation and in recovery room
|
|
|
|
|
|---|---|---|---|
| HR5† | 82.0±11.2 | 93.1±10.6 | 0.0001 |
| HR10† | 84.3±8.7 | 94.0±12.2 | 0.0001 |
| HR20† | 79.3±8.4 | 78.8±6.9 | 0.78 |
| HR30† | 78.3±7.1 | 81.3±7.9 | 0.08 |
| HR60† | 78.9±6.9 | 77.7±6.5 | 0.44 |
| HR R15‡ | 78.0±7.9 | 78.4±8.2 | 0.84 |
| HR R30‡ | 78.4±10.5 | 89.0±11.4 | 0.0001 |
†Heart rate at 5, 10, 20, 30 and 60 minutes after the injection of meperidine (in the experimental group) or normal saline (in the control group); ‡Heart rate at minutes 15 and 30 of arrival in recovery room
Comparison of systolic and diastolic blood pressures of the experimental and control groups during the operation and in recovery room
|
|
|
|
|
|---|---|---|---|
| SBP5¶ | 112.1±20.8 | 90.0±13.2 | 0.0001 |
| DBP5** | 69.9±13.6 | 57.0±12.1 | 0.0001 |
| SBP10¶ | 112.9±13.9 | 94.7±18.5 | 0.0001 |
| DBP10** | 69.8±10.6 | 60.3±14.1 | 0.001 |
| SBP20¶ | 122.8±11.0 | 112.5±14.6 | 0.001 |
| DBP20** | 69.8±16.7 | 60.3±9.6 | 0.02 |
| SBP30¶ | 122.8±21.2 | 112.5±21.4 | 0.13 |
| DBP30** | 75.2±9.2 | 67.9±10.5 | 0.39 |
| SBP60¶ | 140.1±18.6 | 133.1±18.4 | 0.09 |
| DBP60** | 78.6±9.5 | 75.2±8.8 | 0.11 |
| SBPR15† | 133.5±17.8 | 156.3±18.5 | 0.0001 |
| DBPR15‡ | 76.7±9.4 | 82.5±9.5 | 0.009 |
| SBPR30† | 139.7±22.8 | 163.5±14.0 | 0.0001 |
| DBPR30‡ | 76.9±11.9 | 85.8±7.4 | 0.0001 |
¶ Systolic blood pressure (mm Hg) at 5, 10, 20, 30 and 60 minutes after the injection of meperidine (in the experimental group)
or normal saline (in the control group); Diastolic blood pressure (mm Hg) at 5, 10, 20, 30 and 60 minutes after the injection of meperidine (in the experimental group) or normal saline (in the control group); †Systolic blood pressure (mm Hg) atminutes 15 and 30 of arrival in recovery room; ‡Diastolic blood pressure (mm Hg) at minutes 15 and 30 of arrival in recovery room
Analgesia characteristics of experimental and control groups
|
|
|
| |
|---|---|---|---|
| Time to reach maximum sensory sensation† | 5.73±1.42 | 4.82±1.04 | 0.002 |
| Duration of maximum Sensory block to regress to L1† | 118.86±13.62 | 87.17±10.8 | 0.0001 |
| Duration of complete Motor block† | 76.02±5.51 | 78.28±4.54 | 0.82 |
| Duration of analgesia† | 137.28±23.58 | 88.89±8.12 | 0.0001 |
The number and percentage of side effects occurred in experimental and control groups
|
|
|
|
|
|---|---|---|---|
| Hypotension and ephedrine use | 7 (18.4) | 16 (41) | 0.0001 |
| Nausea and vomiting | 9 (23.7) | 2 (5.1) | 0.025 |
| Shivering | 1 (2.6) | 7 (17.9) | 0.056 |
| Pruritus | 5 (12.8) | 0 (0) | 0.055 |
| Need of analgesia | 4 (10.5) | 9 (23.1) | 0.22 |
| Post operation Hemoglobin (gr/dl) | 11.9±1.76 * | 10.7±1.6 * | 0.002 |
| Hemoglobin difference (after-before) | 1.6±1.2 * | 2.8±1.8 * | 0.001 |
| Blood loss in operating room (ml) | 234.2±65.1 | 238.9±75.1 | 0.98 |
| Blood loss in recovery (ml) | 183.4±65.6 | 371.8±171.9 | 0.0001 |